After finding two doses don’t offer enough protection, pfizer and BioNTech are now testing three doses for the youngest age group:
Pfizer and BioNTech are pushing back when they expect to have a vaccine for babies and toddlers.
The companies said that during a routine review they found the lower, 3-microgram dose they had been using during trials seems safe, but doesn’t offer enough protection for the youngest age group . Instead of increasing the dosage, the companies are now testing three doses for its 3-microgram COVID-19 vaccine in kids aged 6 months to 5 years old. According to areleased by the companies on December 17, the third dose will be given at least two months after the second dose.
“If the three-dose study is successful, Pfizer and BioNTech expect to submit data to regulators to support an Emergency Use Authorization for children 6 months to under 5 years of age in the first half of 2022,” the statement says. They will also test a third dose of 10 micrograms in kids aged 5 to 11, as well as a third dose of 10 micrograms or 30 micrograms in study participants aged 12 to 17.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer is testing a 3rd COVID-19 vaccine dose in young kidsPfizer and BioNTech are testing a third dose of their COVID-19 vaccine in an ongoing trial of children ages 6 months to under 5 years, the companies announced F
Weiterlesen »
Pfizer Testing Extra COVID-19 Vaccine Dose For Children Under 5The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn't have as strong an immune response as expected.
Weiterlesen »
Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-OldsThe pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.
Weiterlesen »
Pfizer Requests Full Approval For Covid-19 Vaccine For 12- To 15-Year-OldsThe pharmaceutical company said in November its vaccine gave the age group 100% long-term protection against the virus.
Weiterlesen »
CDC Recommends Pfizer, Moderna Covid-19 Vaccines Over J&J’sHealth authorities said the rate of a rare but serious blood-clotting disorder associated with the Johnson & Johnson shot is higher than previously detected.
Weiterlesen »